Percutaneous image-guided cryoablation: current applications and results in the oncologic field

RL Cazzato, J Garnon, N Ramamurthy, G Koch… - Medical oncology, 2016 - Springer
Percutaneous imaging-guided cryoablation (PICA) is a recently developed technique, which
applies extreme hypothermia to destroy tumours under close imaging surveillance. It is …

Cryoablation and immunotherapy: an overview of evidence on its synergy

BM Aarts, EG Klompenhouwer, SL Rice, F Imani… - Insights into …, 2019 - Springer
Cancer cells can escape the immune system by different mechanisms. The evasion of
cancer cells from immune surveillance is prevented by immune checkpoint inhibitors …

[HTML][HTML] Brusatol suppresses STAT3-driven metastasis by downregulating epithelial-mesenchymal transition in hepatocellular carcinoma

JH Lee, CD Mohan, A Deivasigamani, YY Jung… - Journal of Advanced …, 2020 - Elsevier
Introduction Epithelial-mesenchymal transition (EMT) is a process of transdifferentiation
where epithelial cells attain mesenchymal phenotype to gain invasive properties and thus …

Cryoablation and immunity in non-small cell lung cancer: A new era of cryo-immunotherapy

A Velez, A DeMaio, D Sterman - Frontiers in Immunology, 2023 - frontiersin.org
Despite remarkable advances in tumor response and patient survival in the past decade,
systemic immunotherapies for lung cancer result in an objective response in only around …

[HTML][HTML] Thermal ablation in non-small cell lung cancer: a review of treatment modalities and the evidence for combination with immune checkpoint inhibitors

K Rangamuwa, T Leong, C Weeden… - … lung cancer research, 2021 - ncbi.nlm.nih.gov
Lung cancer is the leading cause of cancer death worldwide, with approximately 1.6 million
cancer related deaths each year. Prognosis is best in patients with early stage disease …

Survival rates after thermal ablation versus stereotactic radiation therapy for stage 1 non–small cell lung cancer: a National Cancer Database Study

J Uhlig, JM Ludwig, SB Goldberg, A Chiang… - Radiology, 2018 - pubs.rsna.org
Purpose To compare survival rates of thermal ablation and stereotactic radiation therapy
(SRT) for stage 1 non-small cell lung cancer (NSCLC). Materials and Methods In this …

Radiofrequency ablation of stage IA non–small cell lung cancer in patients ineligible for surgery: results of a prospective multicenter phase II trial

J Palussière, F Chomy, M Savina, F Deschamps… - Journal of …, 2018 - Springer
Background A prospective multicenter phase II trial to evaluate the survival outcomes of
percutaneous radiofrequency ablation (RFA) for patients with stage IA non-small cell lung …

Image-guided percutaneous ablation for the treatment of lung malignancies: current state of the art

A Páez-Carpio, FM Gómez, G Isus Olivé, P Paredes… - Insights into …, 2021 - Springer
Image-guided percutaneous lung ablation has proven to be a valid treatment alternative in
patients with early-stage non-small cell lung carcinoma or oligometastatic lung disease …

Multiple primary lung cancer: Updates of clinical management and genomic features

H Tian, G Bai, Z Yang, P Chen, J Xu, T Liu, T Fan… - Frontiers in …, 2023 - frontiersin.org
In recent decades, multiple primary lung cancer (MPLC) has been increasingly prevalent in
clinical practice. However, many details about MPLC have not been completely settled, such …

[HTML][HTML] Current technique and application of percutaneous cryotherapy

AH Mahnken, AM König… - RöFo-Fortschritte auf dem …, 2018 - thieme-connect.com
Hintergrund Lokal-ablative Therapien haben sich als wichtiger interventionell-onkologischer
Therapieansatz etabliert. Radiofrequenzablation (RFA) und Mikrowellenablation (MWA) …